{"pub": "news24", "url": "https://fin24.com/Companies/Health/mediclinics-revenue-from-south-africa-reaches-r8bn-share-price-jumps-20191016", "downloaded_at": "2019-10-16 13:53:19.723368+00:00", "title": "Mediclinic\u2019s revenue from South Africa reaches R8bn, share price jumps", "language": "en", "text": "Mediclinic\u2019s share price rose 4% after the company released a trading update for the six months to end-September. Its revenue rose by 6.5%, while its earnings before interest, tax, depreciation and amortisation (Ebitda) rose 3.5%.\n\nIn South Africa, first-half revenue rose 7% to R8bn, with an increase in inpatient bed days of 2.7%. It earned R105m in revenue from its Intercare hospitals \u2013 which owns medical and dental centres as well day hospitals.\n\n\u201cAs expected, Intercare accounted for the majority of growth in the division\u2019s inpatient bed days sold during the period at 2.4%,\u201d Mediclinic said.\n\nIts Swiss business Hirslanden, which treats a third of Switzerland\u2019s private health patients, has in recent months been hit hard by changes in government regulations, which limited payments from medical schemes for hospital nights.\n\nIn response, Hirslanden has initiated a new day case surgery strategy. Hirslanden saw a 5% increase in revenue.\n\nMediclinic a strong performance from its new Mediclinic Parkview Hospital in Dubai and \u201cthe continued gradual improvement in the Abu Dhabi business where Mediclinic Airport Road Hospital delivered good growth\u201d.\n\nMediclinic Middle East saw revenue growth of 8.5%.", "description": "It earned R105m in revenue from its Intercare hospitals.", "authors": [], "top_image": "http://cdn.24.co.za/files/Cms/General/d/1174/c3f6b641ae404dad8f948ea7acaf2852.jpg", "published_at": "2019-10-16"}